|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
3
|
McGranahan N and Swanton C: Biological and
therapeutic impact of intratumor heterogeneity in cancer evolution.
Cancer Cell. 27:15–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou B-BS, Zhang H, Damelin M, Geles KG,
Grindley JC and Dirks PB: Tumour-initiating cells: Challenges and
opportunities for anticancer drug discovery. Nat Rev Drug Discov.
8:806–823. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sachs N and Clevers H: Organoid cultures
for the analysis of cancer phenotypes. Curr Opin Genet Dev.
24:68–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vermeulen L, Todaro M, de Sousa Mello F,
Sprick MR, Kemper K, Perez Alea M, Richel DJ, Stassi G and Medema
JP: Single-cell cloning of colon cancer stem cells reveals a
multi-lineage differentiation capacity. Proc Natl Acad Sci USA.
105:13427–13432. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zeuner A, Todaro M, Stassi G and De Maria
R: Colorectal cancer stem cells: From the crypt to the clinic. Cell
Stem Cell. 15:692–705. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang Y and Eglen RM: Three-dimensional
cell cultures in drug discovery and development. SLAS Discov.
22:456–472. 2017.PubMed/NCBI
|
|
10
|
Karlsson H, Fryknäs M, Larsson R and
Nygren P: Loss of cancer drug activity in colon cancer HCT-116
cells during spheroid formation in a new 3-D spheroid cell culture
system. Exp Cell Res. 318:1577–1585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van de Wetering M, Francies HE, Francis
JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J,
Taylor-Weiner A, Kester L, et al: Prospective derivation of a
living organoid biobank of colorectal cancer patients. Cell.
161:933–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fujii M, Shimokawa M, Date S, Takano A,
Matano M, Nanki K, Ohta Y, Toshimitsu K, Nakazato Y, Kawasaki K, et
al: A colorectal tumor organoid library demonstrates progressive
loss of niche factor requirements during tumorigenesis. Cell Stem
Cell. 18:827–838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Broutier L, Mastrogiovanni G, Verstegen
MMA, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito
R, Sidorova O, Gaspersz MP, et al: Human primary liver
cancer-derived organoid cultures for disease modeling and drug
screening. Nat Med. 23:1424–1435. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang L, Holtzinger A, Jagan I, BeGora M,
Lohse I, Ngai N, Nostro C, Wang R, Muthuswamy LB, Crawford HC, et
al: Ductal pancreatic cancer modeling and drug screening using
human pluripotent stem cell- and patient-derived tumor organoids.
Nat Med. 21:1364–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan C, Hu Y, Zhang B, Mu L, Huang K, Zhao
H, Ma C, Li X, Tao D, Gong J, et al: The CEA-/lo colorectal cancer
cell population harbors cancer stem cells and metastatic cells.
Oncotarget. 7:80700–80715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sato T, Stange DE, Ferrante M, Vries RGJ,
Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J,
Siersema PD, et al: Long-term expansion of epithelial organoids
from human colon, adenoma, adenocarcinoma, and Barrett's
epithelium. Gastroenterology. 141:1762–1772. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mu L, Huang K, Hu Y, Yan C, Li X, Tao D,
Gong J and Qin J: Small-sized colorectal cancer cells harbor
metastatic tumor-initiating cells. Oncotarget. 8:107907–107919.
2017. View Article : Google Scholar
|
|
18
|
Hu Y, Yan C, Mu L, Huang K, Li X, Tao D,
Wu Y and Qin J: Fibroblast-derived exosomes contribute to
chemoresistance through priming cancer stem cells in colorectal
cancer. PLoS One. 10:e01256252015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mahe MM, Aihara E, Schumacher MA, Zavros
Y, Montrose MH, Helmrath MA, Sato T and Shroyer NF: Establishment
of gastrointestinal epithelial organoids. Curr Protoc Mouse Biol.
3:217–240. 2013. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
21
|
Fujii M, Matano M, Nanki K and Sato T:
Efficient genetic engineering of human intestinal organoids using
electroporation. Nat Protoc. 10:1474–1485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pastrana E, Silva-Vargas V and Doetsch F:
Eyes wide open: A critical review of sphere-formation as an assay
for stem cells. Cell Stem Cell. 8:486–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Drost J and Clevers H: Organoids in cancer
research. Nat Rev Cancer. 18:407–418. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
25
|
Shimokawa M, Ohta Y, Nishikori S, Matano
M, Takano A, Fujii M, Date S, Sugimoto S, Kanai T and Sato T:
Visualization and targeting of LGR5+ human colon cancer
stem cells. Nature. 545:187–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitra A, Mishra L and Li S: Technologies
for deriving primary tumor cells for use in personalized cancer
therapy. Trends Biotechnol. 31:347–354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Centenera MM, Raj GV, Knudsen KE, Tilley
WD and Butler LM: Ex vivo culture of human prostate tissue and drug
development. Nat Rev Urol. 10:483–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Portillo-Lara R and Alvarez MM: Enrichment
of the cancer stem phenotype in sphere cultures of prostate cancer
cell lines occurs through activation of developmental pathways
mediated by the transcriptional regulator ΔNp63α. PLoS One.
10:e01301182015. View Article : Google Scholar
|
|
29
|
Lau WM, Teng E, Chong HS, Lopez KA, Tay
AY, Salto-Tellez M, Shabbir A, So JB and Chan SL: CD44v8–10 is a
cancer-specific marker for gastric cancer stem cells. Cancer Res.
74:2630–2641. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qin J, Liu X, Laffin B, Chen X, Choy G,
Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, et al: The
PSA(-/lo) prostate cancer cell population harbors self-renewing
long-term tumor-propagating cells that resist castration. Cell Stem
Cell. 10:556–569. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu YB, Yan C, Mu L, Mi YL, Zhao H, Hu H,
Li XL, Tao DD, Wu YQ, Gong JP, et al: Exosomal Wnt-induced
dedifferen-tiation of colorectal cancer cells contributes to
chemotherapy resistance. Oncogene. Nov 2–2018.Epub ahead of print.
View Article : Google Scholar
|
|
32
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M,
Merz C, Rodermond H, et al: Wnt activity defines colon cancer stem
cells and is regulated by the microenvironment. Nat Cell Biol.
12:468–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsu HH, Chen MC, Baskaran R, Lin YM, Day
CH, Lin YJ, Tu CC, Vijaya Padma V, Kuo WW and Huang CY: Oxaliplatin
resistance in colorectal cancer cells is mediated via activation of
ABCG2 to alleviate ER stress induced apoptosis. J Cell Physiol.
233:5458–5467. 2018. View Article : Google Scholar
|
|
35
|
Cassidy JW, Caldas C and Bruna A:
Maintaining tumor heterogeneity in patient-derived tumor
xenografts. Cancer Res. 75:2963–2968. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bruna A, Rueda OM, Greenwood W, Batra AS,
Callari M, Batra RN, Pogrebniak K, Sandoval J, Cassidy JW,
Tufegdzic-Vidakovic A, et al: A biobank of breast cancer explants
with preserved intra-tumor heterogeneity to screen anticancer
compounds. Cell. 167:260–274.e22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Aparicio S, Hidalgo M and Kung AL:
Examining the utility of patient-derived xenograft mouse models.
Nat Rev Cancer. 15:311–316. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Drost J, van Boxtel R, Blokzijl F,
Mizutani T, Sasaki N, Sasselli V, de Ligt J, Behjati S, Grolleman
JE, van Wezel T, et al: Use of CRISPR-modified human stem cell
organoids to study the origin of mutational signatures in cancer.
Science. 358:234–238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Seino T, Kawasaki S, Shimokawa M, Tamagawa
H, Toshimitsu K, Fujii M, Ohta Y, Matano M, Nanki K, Kawasaki K, et
al: Human pancreatic tumor organoids reveal loss of stem cell niche
factor dependence during disease progression. Cell Stem Cell.
22:454–467.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dijkstra KK, Cattaneo CM, Weeber F,
Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL,
Kaing S, Kelderman S, et al: Generation of tumor-reactive T cells
by co-culture of peripheral blood lymphocytes and tumor organoids.
Cell. 174:1586–1598.e12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Batlle E and Clevers H: Cancer stem cells
revisited. Nat Med. 23:1124–1134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar
|
|
44
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hema-topoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sun S, Liu S, Duan SZ, Zhang L, Zhou H, Hu
Y, Zhou X, Shi C, Zhou R and Zhang Z: Targeting the c-Met/FZD8
signaling axis eliminates patient-derived cancer stem-like cells in
head and neck squamous carcinomas. Cancer Res. 74:7546–7559. 2014.
View Article : Google Scholar : PubMed/NCBI
|
